Israeli Diagnostics Firm Launches AI Solution To Detect Gastrointestinal Cancer
The cancer diagnostics firm Ibex will deploy the new AI system at the research and innovation center of Israel's second largest HMO Maccabi.
August 26, 2021
AI Cancer Diagnostics Firm Ibex Granted FDA Breakthrough Device Designation
The designation is for the Ibex Galen platform, a solution that helps pathologists detect and grade cancer in biopsies.
June 09, 2021
AI Diagnostics Firm Ibex Medical Closes $38M Funding Round
Ibex Medical develops clinical-grade, AI-based solutions that help pathologists detect and grade cancer in biopsies.
March 10, 2021
AI Diagnostics Firm Ibex To Pilot Breast Cancer Screening Tool With Israeli HMO
Ibex's screening solution helps pathologists improve accuracy and reduce turnaround time for breast cancer diagnoses.
December 16, 2020
Israeli AI Diagnostics Firm Ibex Detects Cancer Using Advanced Algorithms
Ibex Medical Analytics' AI-powered technology helps pathologists detect and grade cancer in biopsies.
July 30, 2020
Israeli AI Diagnostics Firm Ibex To Roll Out Cancer Screening For NHS Patients In UK
Founded in 2014, Ibex develops clinical-grade, AI-based solutions that help pathologists detect and grade cancer in biopsies
June 30, 2020
